
IGC Pharma Adds Ichor Research as New Site for CALMA Phase 2 Alzheimer’s Trial
POTOMAC, MD, September 29, 2025 / IGC Pharma, Inc. (NYSE American: IGC) today announced the addition of a new clinical trial site to its ongoing Phase 2 study evaluating IGC-AD1, an